Clinical Trials Browser

Phase 1/2 × INDUSTRY × azeliragon × Clear all

NCT05635734 2026-02-05

Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma

Phase 1/2 Active not recruiting

Glioblastoma

NCT05766748 2024-06-14

Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms